Purified lipopolysaccharide (LPS) from smooth (S) and rough (R) strains of Brucella abortus and lipid A isolated from S-LPS by mild acid hydrolysis were examined in several assays of biological activity. Brucella S-and R-LPSs and Brucella lipid A activated the complement cascade. Previously reported mitogenic activation by Brucella LPSs of spleen cells from endotoxin-resistant C3H/ HeJ mice was confirmed and also produced by isolated Brucella lipid A. Mitogenicity was not inhibited by polymyxin B, and amino acid analysis showed no binding of polymyxin B to Brucella LPS under conditions in which mitogenicity of phenol-water-extracted Escherichia coli LPS was inhibited. S and R Brucella LPSs and lipid A all produced equivalent polyclonal stimulation of C3H/HeJ and C3H/HeAU spleen cells. Crude and purified LPS from S but not from R B. abortus was toxic for outbred mice, with 50% lethal doses approximately six times greater than that for E. coli LPS. S-and R-LPSs were abortifacient in pregnant outbred mice. S Brucella LPS was lethal for carrageenen-pretreated C3H/HeJ and C3H/HeAU mice, whereas only C3H/HeAU mice were killed by E. coli LPS. The data are consistent with the hypothesis that the unique fatty acid composition of Brucella lipid A is responsible for its biological activity in endotoxin-resistant C3H/HeJ mice. The participation of the protein strongly bound to the lipid A cannot be excluded, but its mode of action, if any, is different from that of the lipid A-associated protein of enterobacterial LPS.
A very large body of information has been developed over the past 20 years which relates biological activity and the structure of lipopolysaccharides (LPSs) of the Enterobacteriaceae. Most of the large constellation of biological effects which they exhibit have been associated with the lipid A moiety, which is quite uniform among the enterobacterial LPSs (5, 20) . A number of lipid As have been recognized which have structural features different from those of enterobacterial lipid As, and they have also been shown to have unique biological properties (12, 36) . Crude preparations of LPS from smooth (S) Brucella have been known for more than 15 years to share some of the biological properties of enterobacterial LPS and to be unique in other respects (8, 19) , but systematic examination of chemical structure-biological activity relationships has been hampered by the difficulty in preparing highly purified and well-characterized LPSs from Brucella. We have recently described methods for purification of Brucella LPS and shown that it has a fatty acid composition quite distinct from that of enterobacterial LPS. Specifically, Brucella LPS lacks ,8-OH myristic acid, and it contains seven major fatty acids accounting for 85% of the total fatty acids, all of which have equivalent chain lengths of 16 or greater (24) . In addition, S Brucella LPS has a strongly bound protein, accounting for approximately 6% of the purified preparations, which cannot be dissociated under conditions which remove the lipid A-associated protein (LAP) of enterobacterial LPS (23, 24) . Purified rough (R) Brucella LPS, with the same fatty acid composition as S Brucella LPS, contains only 1.5% protein and has different physical properties. Purified S and R Brucella LPSs are both mitogenic for spleen cells of endotoxin-resistant C3H/HeJ mice, and activity is not proportional to protein content of the preparations. This led us to the conclusion that the unique fatty acid composition of the Brucella lipid A was probably the major factor responsible for some of the distinctive biological activities of Brucella LPS (23) . We now report on experiments designed to define for the first time the activity of purified and well-characterized LPSs from S and R B. abortus and of the lipid A isolated from the S-LPS in several additional established endotoxin assays, and to examine further the possible role of the protein associated with Brucella lipid A in its biological activity.
MATERIALS AND (18) .
Source and characteristics of LPSs. The extraction by phenol-water, purification, chemical analyses, and characterization of S-LPS from Brucella abortus 1119-3 and R-LPS from B. abortus 45/20 have been described previously (24) . The same chemical analytical methods were used for this work. Two different preparations of S-LPS and one of R-LPS were used: (i) crude S-LPS (f5), (ii) purified S-LPS (f5p), (iii) purified R-LPS (R3a). In addition, endotoxin from B. abortus 1119-3 was extracted with trichloroacetic acid (3) .
National Reference Standard Endotoxin from Escherichia coli 0113 prepared by phenol-water extraction (PW-LPS) was obtained from the Bureau of Biologics, Food and Drug Administration. The characteristics of this preparation have been described by Rudbach et al. (31) . Endotoxin from E. coli 0128:B12 extracted with trichloroacetic acid (TCA-LPS) was purchased from Difco Laboratories, Detroit, Mich. E. coli LPS from serotype 0128:B12, extracted with phenol-water (Difco), was purified by ultracentrifugation as described by Westphal and Jann (37) . In addition, E. coli LPS from serotype O111:B4, extracted with trichloroacetic acid, and S-LPS from Salmonella typhimurium, extracted with phenol-water from Difco, were used for assay of anticomplementary action. Analyses for protein were not made.
Preparation of lipid A and specific degraded polysaccharide from LPS. E. coli lipid A was obtained by hydrolysis of E. coli O111:B4 PW-LPS with 1% acetic acid at 100°C for 1 h (11, 16) . Brucella lipid A and the water-soluble degraded polysaccharide (AH) were obtained by the same method from f5p, except that hydrolysis for 5 h was required to release all of the lipid A. AH was purified by column chromatography on G-50 Sephadex with pyridine buffer, dialyzed, and lyophilized as described by Jann et al. (16) .
The precipitate formed after acid hydrolysis, which was composed mainly of lipid A, was washed six times in double-distilled water, suspended in 5 ml of doubledistilled water, and dissolved with 10 pl of triethylamine. The insoluble residue was sedimented at 10,000
x g, the supernatant fluids were removed, and the sediment was suspended in triethylamine as described above. The supernatant fluids were pooled, and the procedure was repeated an additional time. The excess triethylamine was removed from the pooled supernatant fluids containing solubilized lipid A by dialysis against double-distilled water for 2 weeks. Part of the soluble lipid A was stored at 40C until used. The rest was lyophilized and either used for chemical analysis or adsorbed to bovine serum albumin (lipid A-BSA). Brucella lipid A contained 51% fatty acid amide plus fatty acid ester, 15% protein, and 12% carbohydrate; 2-keto-3-deoxyoctonate was not detectable by thiobarbituric acid assay (24) .
Preparation of poly B. Crude polysaccharide B (poly B), the "native cytoplasmic polysaccharide" of R B. melitensis B115, was extracted with trichloroacetic acid by a modification of the method of Boivin and Mesrobeanu (3, 7) . It contained 83% carbohydrate, 50% nucleic acids, and 5% protein. Poly B was freed of nucleic acid and protein by the following method: a suspension of 75 mg of lyophilized poly B in 9 ml of phosphate-buffered saline was treated with 0.75 mg of ribonuclease and 0.75 mg of.deoxyribonuclease (both from Sigma), and the mixture was stirred for 18 h at room temperature and finally heated at 100°C for 2 h. The preparation was clarified by centrifugation at 800 x g for 15 min, followed by centrifugation at 106,000 x g for 6 h, and the supernatant fluid was finally lyophilized. It contained 96% carbohydrate, approximately 2% nucleic acids and <1% protein. 2-Keto-3-deoxyoctonate and lipid were not detectable.
Treatment of LPS with polymyxin B. LPS preparations were treated with polymyxin B sulfate (Sigma) as described by Morrison and Jacobs (26) . Fifteen milligrams of polymyxin B was added to 1 ml of LPS solution at a concentration of 5 mg/ml. After 30 min at room temperature, the solution was dialyzed extensively against double-distilled water. Binding of polymyxin B to LPS was determined by automated analysis of hydrolysates, using ninhydrin reagent in a Durrum D-500 (Dionex) amino acid analyzer. The conditions of acid hydrolysis used permitted the detection of S nmol of each amino acid per sample, including a,y-aminobutyric acid present in the polymyxin B standard (22) .
Solubilization of R3a and lipid As. R3a and the lipid As were each solubilized by adsorption to BSA (R3a-BSA or lipid A-BSA) as described by Galanos et al. (11) .
Limulus lysate gelation activity. The Limulus lysate gelation assay was carried out as described by Sullivan and Watson (32) . Activity was expressed as the lowest concentration in nanograms per milliliter needed to form a solid gel.
Anticomplementary activity. The test for the interaction of LPS and LPS-derived products with complement was performed by a modification of the method of Galanos and Luderitz (10) . Fresh guinea pig serum from eight animals was pooled and absorbed with sheep erythrocytes at 00C, distributed in 1-ml quantities, and stored at -60°C. Amounts of LPS or product ranging from 1 to 100 jig in 20 pl of pyrogenfree distilled water were incubated with 100 pl of fresh guinea pig serum diluted 1:2 with barbital buffer (pH 7.4) at 37°C for 30 min. The samples were then diluted with 400 pl of buffer, and 20 pl of diluted sample was added to 1.5 ml of barbital buffer, containing 2.5 x 108 sensitized sheep erythrocytes, and incubated at 370C for 1 h. The samples were centrifuged at 40C, and hemoglobin release was recorded as absorbance by the supernatant fluids at 546 nm. Under these conditions, the hemolytic activity of the complement without LPS corresponded to lysis of 40 to 50% of the standard VOL. 31 (Fig. 1) . In agreement with the observations of Galanos and Luderitz (10), higher concentrations of LPS or lipid A-BSA produced spontaneous hemolysis of the erythrocytes.
Mitogenicity. Since polymyxin B has been shown to inhibit the mitogenicity of E. coli PW- The mitogenic activity of soluble Brucella lipid A and lipid A-BSA at different concentrations is shown in Fig. 3 . Higher doses of these lipid A preparations were not tested because of the large quantities required. The responses of the C3H/HeJ cells to E. coli TCA-LPS were unusually low in this experiment as compared with responses usually seen in comparable experiments ( Fig. 2 and reference 23 ), but the responses were significantly greater than those seen in control cultures. Mitogenic activity was not observed with AH or poly B at concentrations of 50 to 100 ,ug/ml.
Polyclonal activation. Data from a typical experiment on polyclonal activation of spleen cells of C3H/HeAU, C3H/HeJ, and nude mice by f5p, R3a-BSA, soluble Brucella lipid A, and E. coli PW-LPS are presented in Table 3 . Maximum polyclonal activation was observed at concentrations of 50 and 100 ,ug of LPS or soluble lipid A per 5 x 106 cells in 1 ml of medium.
Toxicity. Lambda carrageenan was the most powerful of the three types tested in potentiating the toxicity of LPS. However, it was also the most toxic, killing 25 to 50% of outbred ICR control mice within 48 h, at concentrations between 0.8 and 1 mg of carrageenan per mouse. Kappa carrageenan had little toxicity for mice and little potentiating activity for the LPSs used. Iota carrageenan was the most useful potentiating agent. It had low toxicity for control mice and relatively good potentiating activity, especially for E. coli LPS; 10 mg of iota carrageenan per mouse potentiated the toxicity of E. coli LPS 50-to 100-fold. A combination of 0.5 mg of lambda carrageenan with 9.5 mg of iota carrageenan per mouse was found to potentiate the toxic activity of E. coli and Brucella LPSs optimally (Table 4 sistent with the reports of others (28, 33) , 2 mg of LAP-free E. coli LPS (PW-LPS) did not kill C3H/HeJ mice. Table 5 shows the abortifacient and toxic effects of E. coli TCA-LPS, f5, f5p, and R3a-BSA in pregnant ICR mice. E. coli TCA-LPS was more toxic than any of the Brucella LPSs. R3a-BSA, which was not toxic in inbred mice pretreated with carrageenan at concentrations of 800 ,jg of R3a-BSA per mouse ( (6, 27) . It has also been demonstrated (9, 10) Expressed as 100 pg of R3a per ml.
the Brucella R3a-BSA had more anticomplementary activity than several lots of f5 and f5p, as weil as the striking differences in anticomplementary activity produced by soluble Brucella lipid A and lipid A-BSA. The difficulty of establishing the immunostimulatory role of the protein strongly bound to Brucella LPS and lipid A is shown by the experiments on mitogenicity and polyclonal antibody production. Jacobs and Morrison (15, 25) concluded that polymyxin B inhibits mitogenic activity of LAP-free LPS from E. coli or Salmonella by binding to the lipid A-2-keto-3-deoxyoctonate moiety of the LPS molecule. Betz and Morrison (2) also showed that polymyxin B did not inhibit the mitogenicity of isolated LAP, and they proposed this as a useful differential characteristic. The failure of polymyxin B to reduce the mitogenic activity of Brucella LPSs is in sharp contrast with the complete inhibition of mitogenic activity of E. coli PW-LPS and the reduction of activity of E. coli TCA-LPS (Fig.  2) . The inability of polymyxin B to bind to f5 and f5p, as shown by amino acid analysis, constitutes additional evidence for the unique struc- (2) showed that isolated enterobacterial LAP preparations had a characteristic dose-response profile in mitogenicity assays with both C3H/HeSt and C3H/HeJ cells. Optimal stimulation was at a concentration of approximately 10 ,ug of LAP per ml; higher concentrations were toxic and resulted in sharply less [3H]thymidine incorporation. They presented evidence for slight inhibition of mitogenicity at high doses of LAP-LPS complex, but not with high doses of LAP-free LPS. Similar results were reported by Izui et al. (14) . In our experiments, the dose-response profile ofthe mitogenic response induced by Brucella lipid A-BSA in spleen cells of C3H/HeAU and C3H/HeJ mice was similar to that previously observed with f5p but not with R3a-BSA or E. coli PW-LPS (23) . That is, concentrations of lipid A-BSA or f5p greater than 100 ,Lg/ml did not depress the mitogenic response of the cells, whereas the mitogenic response to R3a-BSA, E. coli PW-LPS, or E. coli TCA-LPS at concentrations greater than 100 ,ug/ml was regularly depressed below that observed with 100 ug/ml. Becker and Rudbach (1) reported that mice pretreated with carrageenan were between 1,000-and 2,000-fold more sensitive to the toxic effects of E. coli LPS than normal mice. We observed only a 50-to 100-fold increase in sensitivity to both Brucella and E. coli LPSs, including the E. coli PW-LPS which was prepared by Rudbach et al. (31) . There is no obvious explanation for the failure ofhigh concentrations of Brucella f5 or f5p to kill 100% of the carrageenan-pretreated mice. This finding is not unique since the same phenomenon has been observed with other endotoxin preparations from Brucella and with acetone-killed Brucella cells (18) . The lack of toxicity of Brucella endotoxin for chicken embryos and rabbits, its very low pyrogenicity (8, 19) , and the generally lower toxicity of Brucella S-LPS for mice are all consistent with the hypothesis that the mediation of its toxicity may be unique.
In agreement with the reports of Urbaschek (34, 35) , crude Brucella S-LPS (f5) was abortifacient for pregnant mice, as was f5p. The difference in activity observed between the two lots of f5p may be due to the particular preparations used, since in these experiments the fractions came from different batches of f5.
Our finding that R3a did not kill mice was unexpected, as it had previously been shown in this laboratory that a hot-saline extract of Brucella ovis containing R-LPS and approximately 70% protein was toxic for mice (18) . In contrast, R3a, with 1.5% protein, 27% lipid, and high Limulus lysate gelation activity, and which was a mitogen and a potent polyclonal activator for mouse spleen cells, did not kill mice. This result is apparently in conflict with our hypothesis that both mitogenicity and toxicity are related to the unique fatty acid composition of the lipid As from S and R Brucella LPSs. However, Brucella lipid A (15% protein) was less toxic than the f5p (6.3% protein) from which it was prepared, killing only 3 of 10 carrageenan-pretreated mice at a dose of 100 ,ug of lipid A. It is likely that the state of aggregation of the LPSs and lipid A is modified by the presence or absence of 0 polysaccharide or of particular proteins and that this influences its endotoxic activity (30) , as is also the case with anticomplementary activity (10) .
To resolve the unsettled questions, it will be necessary to do further work, including experiments on adjuvant activity and effects on toler- 
